Erythrodermic Psoriasis Managed with Risankizumab

Erythrodermic psoriasis (EP) is a severe, often refractory, variant of psoriasis. Due to the high morbidity and mortality rate associated with EP and other causes of erythroderma, they are often classified as dermatologic emergencies. EP is usually a therapeutic challenge, where topical and conventi...

Descripción completa

Detalles Bibliográficos
Autores principales: Alajlan, Abdulmajeed, Madani, Abdulaziz, Qadoumi, Tala Ammar, Aljaloud, Alhanouf, Alessa, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459644/
https://www.ncbi.nlm.nih.gov/pubmed/36158862
http://dx.doi.org/10.1159/000525774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459644/
https://www.ncbi.nlm.nih.gov/pubmed/36158862
http://dx.doi.org/10.1159/000525774

Ejemplares similares